<?xml version="1.0" encoding="UTF-8" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
    <channel>
        <title>Value Research Online</title>
        <atom:link href="/stories/stock/108758/eris-lifesciences-ltd/rss" rel="self" type="application/rss+xml" />
        <link>https://www.valueresearchonline.com/</link>
        <description>RSS Feeds | Value Research</description>
        <language>en</language>
        <copyright>Copyright 2026 Value Research India Private Limited.</copyright>
        <image>
            <title>Value Research</title>
            <url>https://www.valueresearchonline.com/assets/images/valueresearchonline-desktop.png</url>
            <link>https://www.valueresearchonline.com/</link>
        </image>

        <item>
			<title>Pharmaceutical formulations giant made an acquisition worth Rs 1,242 crore!</title>
			<link>https://www.valueresearchonline.com/stories/54600/pharmaceutical-formulations-giant-made-an-acquisition-worth-rs-1242-crore/</link>
			<pubDate>Mon, 18 Mar 2024 12:29:19 +0530</pubDate>
			<category>Stockwire</category>
			<description>&lt;img src=&quot;https://www.valueresearchonline.com/content-assets/images/54600_eris-lifesciences-announces-acquisition-of-biocon-biologics-for-rs-1250-crore__w320__h240__.jpg&quot; alt=&quot;Eris Lifesciences acquires Biocon&#039;s branded division for Rs 1,242 cr&quot; border=&quot;0&quot; width=&quot;320&quot; height=&quot;240&quot; style=&quot;float: left; margin-right: 5px;&quot;&gt;Eris Lifesciences announces acquisition of Biocon Biologics&#039; branded formulation division, marking a significant move into the Indian injectables market.</description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/54600/pharmaceutical-formulations-giant-made-an-acquisition-worth-rs-1242-crore/</guid>
		</item>
		<item>
			<title>Inside ROE</title>
			<link>https://www.valueresearchonline.com/stories/46552/inside-roe/</link>
			<pubDate>Mon, 11 Feb 2019 11:47:05 +0530</pubDate>
			<category>Marketwire</category>
			<description>&lt;img src=&quot;https://www.valueresearchonline.com/content-assets/images/46552_inside-roe__w320__h240__.jpg&quot; alt=&quot;Inside ROE&quot; border=&quot;0&quot; width=&quot;320&quot; height=&quot;240&quot; style=&quot;float: left; margin-right: 5px;&quot;&gt;The DuPont formula segments ROE and helps us make more sense of it</description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/46552/inside-roe/</guid>
		</item>
		<item>
			<title>Mutual funds make the most of IPOs</title>
			<link>https://www.valueresearchonline.com/stories/34528/mutual-funds-make-the-most-of-ipos/</link>
			<pubDate>Wed, 18 Oct 2017 05:37:31 +0530</pubDate>
			<category>Fundwire</category>
			<description>&lt;img src=&quot;https://www.valueresearchonline.com/content-assets/images/34528_ipo_graph__w320__h240__.png&quot; alt=&quot;Mutual funds make the most of IPOs&quot; border=&quot;0&quot; width=&quot;320&quot; height=&quot;240&quot; style=&quot;float: left; margin-right: 5px;&quot;&gt;Here&#039;s a brief look at how Indian mutual funds have reacted to the recent IPO craze</description>
			<guid isPermaLink="true">https://www.valueresearchonline.com/stories/34528/mutual-funds-make-the-most-of-ipos/</guid>
		</item>
    </channel>
</rss>
